One pharmaceutical stock is up an insane 280% and has been halted 6 times today
The last two trading sessions have been wild for Aquinox Pharmaceuticals.
On Friday, shares spiked by up to 400% after the company reported earnings numbers, and positive trial results for a drug that treats bladder pain syndrome.
On Monday, the stock surged by up to 365%. It's now up more than 1000% from Thursday's closing price of $1.79 per share.
This type of move higher (or lower) is not all that uncommon for pharmaceutical and biotech companies, whose revenues are sometimes underpinned by one key drug that has to pass through several trials before it hits the shelves.
Aquinox Pharma is now worth about $422 million.
Trading was halted at least six times in the first two hours of trading on Monday, after it crossed so-called circuit breaker limits that aim to reduce volatility.
Google Finance
- US buys 81 Soviet-era combat aircraft from Russia's ally costing on average less than $20,000 each, report says
- 2 states where home prices are falling because there are too many houses and not enough buyers
- A couple accidentally shipped their cat in an Amazon return package. It arrived safely 6 days later, hundreds of miles away.
- Why did a NASA spacecraft suddenly start talking gibberish after more than 45 years of operation? What fixed it?
- ICICI Bank shares climb nearly 5% after Q4 earnings; mcap soars by ₹36,555.4 crore
- Markets rebound sharply on buying in bank stocks firm global trends
- Bengaluru's rental income highest in Q1-2024, Mumbai next: Anarock report
- Rupee falls 10 paise to settle at 83.48 against US dollar